Erratum: A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease (Gastroenterology (2005) 129 (807-818))

Journal article

S Schreiber, P Rutgeerts, RN Fedorak, M Khaliq-Kareemi, MA Kamm, M Boivin, CN Bernstein, M Staun, O Thomsen, A Innes

Gastroenterology | Published : 2005